Next 10 |
home / stock / chyhy / chyhy news
2024-03-06 01:43:24 ET Summary Novozymes reported its last annual results for fiscal 2023 with revenue growing, but bottom line declining. Novonesis is the new company generated by the merger between Novozymes and Christian Hansen. The stock is trading above intrinsic value on...
2023-12-26 15:52:05 ET Summary Chr. Hansen Holding A/S is a Danish company with above-average growth potential in the enzymes business. The company recorded strong financial performance with 16% organic revenue growth and double-digit growth in core segments. The pending merge...
2023-12-21 10:27:09 ET Summary Novozymes and Chr. Hansen are close to completing their merger, creating a global bio-solutions leader with strong competitive moats. The combined company is expected to deliver higher revenue growth and increased profitability through cost and reven...
2023-10-12 15:05:26 ET Chr. Hansen Holding A/S (CHYHY) Q4 2023 Earnings Conference Call October 12, 2023, 4:00 AM ET Company Participants Mauricio Graber - President and Chief Executive Officer Lise Skaarup Mortensen - Executive Vice President and Chief Financial Off...
2023-10-10 21:54:11 ET Summary Novozymes' stock is declining for almost two years and has lost almost 50% of its previous value. The company reported mediocre half-year results for fiscal 2023. But Novozymes has a wide economic moat around its business, making the company a go...
2023-08-23 21:09:06 ET Summary Christian Hansen is a Danish company with premiumization and low yield, but offers above-average growth potential. Enzymes business, including Christian Hansen, has seen a decline in the past month, presenting a buying opportunity for long-term inves...
2023-07-20 17:05:44 ET Summary Danish bioscience company Chr. Hansen, which specializes in the commercial production of enzymes, has impressive gross margins of over 54% and net margins of over 17%. Despite weak market trends, the company has reported near-double-digit organic rev...
2023-07-06 14:29:43 ET Chr. Hansen Press release ( OTCPK:CHYHY ): Q3 GAAP EPS of Є0.45. Revenue of Є355M (+11.6% Y/Y). For further details see: Chr. Hansen GAAP EPS of Є0.45, revenue of Є355M
2023-07-06 11:59:06 ET Chr. Hansen Holding A/S (CHYHY) Q3 2022 Earnings Conference Call July 06, 2023, 4:00 AM ET Company Participants Mauricio Graber - President and Chief Executive Officer Lise Mortensen - Executive Vice President and Chief Financial Officer ...
2023-06-02 05:36:23 ET Summary Danish companies Novozymes and Christian Hansen have announced plans to merge, creating a leading global biosolutions company. The merger is expected to be completed in late 2023 or early 2024, following regulatory approval. Despite the wide econ...
News, Short Squeeze, Breakout and More Instantly...
CHR Hansen Holding A/S ADR Company Name:
CHYHY Stock Symbol:
OTCMKTS Market:
CHICAGO , July 28, 2020 /PRNewswire/ -- Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingred...